Pfizer has announced that its vaccine is 95% effective on the basis of its Phase-3 trials. On Friday, Pfizer said that it is asking US regulators to allow the emergency use of its Covid-19 vaccine.
The company announced that they will submit a request to the US Food and Drug Administration (FDA) for Emergency Use Authorisation, which will potentially enable the use of the vaccine in high-risk populations in the US by mid to end of December 2020.
“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of Covid-19 globally. Filing in the US represents a critical milestone in our journey to deliver a Covid-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr Albert Borla, Pfizer CEO and chairman.
A severe cold wave is gripping North India, bringing dense fog, heavy rains, and freezing…
Most of the WMF list includes sites in conflict zones, such as Ukraine and Gaza,…
After the RDX blast took place at the residence of Punjab Congress leader from Batala,…
The shocking incident at Saif Ali Khan’s residence, which took place in the early hours…
Hours after the Calcutta High Court pulled up the Mamata Banerjee Government for not taking…
The wildfires have ravaged large portions of the LA area, igniting in Pacific Palisades and…